← All companies

OPK

OPKO Health, Inc.

OPK Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.31

-0.03 -2.24%

Key statistics

from XBRL data in SEC filings

Market cap

$978M

Revenue (TTM)

$588M

Net income (TTM)

-$72.9M

EPS (TTM)

$-0.09

P/E ratio

—

Dividend yield

—

Free cash flow

-$191M

Cash

$301M

Total assets

$1.83B

Gross margin

40.8%

52-week range

$0.98 – $1.73

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 27, 2026 8-K Results of operations (earnings release) Jul 27, 2026 8-K Shareholder vote results Jun 18, 2026 10-Q Quarter ended 2026-03-31 Apr 28, 2026 8-K Results of operations (earnings release) Apr 28, 2026 8-K Director or officer change Mar 19, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 10-Q Quarter ended 2025-09-30 Oct 29, 2025 8-K Results of operations (earnings release) Oct 29, 2025 8-K Regulation FD disclosure; Other events Sep 15, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release) Jul 31, 2025 8-K Director or officer change May 29, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) Apr 30, 2025 8-K Shareholder vote results Apr 23, 2025 8-K Entered a material agreement; Unregistered sale of equity Apr 1, 2025 8-K Entered a material agreement; Unregistered sale of equity Mar 28, 2025 10-K/A Fiscal year ended 2024-12-31 Mar 21, 2025 8-K Entered a material agreement; Regulation FD disclosure Mar 11, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Regulation FD disclosure Jan 15, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Terminated a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Sep 16, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Director or officer change Jul 29, 2024 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Jul 17, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Shareholder vote results Mar 29, 2024 8-K/A Regulation FD disclosure Mar 28, 2024 8-K Entered a material agreement; Regulation FD disclosure Mar 28, 2024 10-K Fiscal year ended 2023-12-31 Mar 1, 2024 8-K Results of operations (earnings release) Feb 27, 2024 8-K Director or officer change Feb 9, 2024 8-K Other events Jan 24, 2024